Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Fibrosarcoma

pyrroles has been researched along with Fibrosarcoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akerman, S; Barber, PR; Bjorndahl, M; Daniel, RA; Evans, H; Fisher, M; Harris, S; Kanthou, C; Lefley, D; Lunt, SJ; Prise, VE; Reyes-Aldasoro, CC; Tozer, GM; Vojnovic, B; Williams, LJ1
Dimberg, A; Georganaki, M; Huang, H; Mangsbo, SM; van Hooren, L1
Almerico, AM; Barraja, P; Cirrincione, G; Dall'Acqua, F; Dattolo, G; Diana, P; Lauria, A; Montalbano, A; Viola, G1
Bucana, CD; Fidler, IJ1
Ansiaux, R; Baudelet, C; Crokart, N; DeWever, J; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Martinive, P1
Arnaud, L; Bousquet, G; Kerob, D; Lebbe, C; Madelaine, I; Sarandi, F; Schartz, NE; Verola, O1
Cherrington, JM; Griffin, RJ; Park, H; Song, CW; Wild, R; Williams, BW1

Other Studies

7 other study(ies) available for pyrroles and Fibrosarcoma

ArticleYear
Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.
    International journal of cancer, 2013, Dec-01, Volume: 133, Issue:11

    Topics: Animals; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice; Neovascularization, Pathologic; Protein Isoforms; Pyrroles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2013
Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.
    Oncotarget, 2016, Jul-01, Volume: 7, Issue:31

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; CD11b Antigen; CD40 Antigens; Cell Line, Tumor; Dendritic Cells; Drug Synergism; Endothelial Cells; Fibrosarcoma; Indoles; Intercellular Adhesion Molecule-1; Kaplan-Meier Estimate; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Pyrroles; Sunitinib; T-Lymphocytes, Cytotoxic; Up-Regulation; Vascular Cell Adhesion Molecule-1

2016
Pyrrolo[2,3-h]quinolinones: synthesis and photochemotherapic activity.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Fibrosarcoma; Humans; Photochemotherapy; Photosensitizing Agents; Pyrroles; Quinolones; Structure-Activity Relationship; Tumor Cells, Cultured

2003
Bioassay using epidermal keratinocytes to determine phosphorylation status of the epidermal growth factor receptor in distant neoplasms.
    International journal of oncology, 2004, Volume: 24, Issue:1

    Topics: Animals; Benzimidazoles; Biological Assay; Cell Line, Tumor; Dose-Response Relationship, Drug; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Fibrosarcoma; Keratinocytes; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Neoplasm Transplantation; Phosphorylation; Pyrimidines; Pyrroles; Specific Pathogen-Free Organisms

2004
Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy.
    Cancer research, 2006, Oct-01, Volume: 66, Issue:19

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Combined Modality Therapy; Cyclophosphamide; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fibrosarcoma; Indoles; Liver Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitochondria; Oxygen; Oxygen Consumption; Pyrroles; Radiation-Sensitizing Agents

2006
Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9

    Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Coma; Fatal Outcome; Female; Fibroma; Fibrosarcoma; Humans; Indoles; Liver Neoplasms; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Treatment Failure

2008
Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
    Cancer research, 2002, Mar-15, Volume: 62, Issue:6

    Topics: Animals; Cell Division; Chemotherapy, Adjuvant; Female; Fibrosarcoma; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Oxindoles; Pancreatic Neoplasms; Propionates; Pyrroles; Radiation-Sensitizing Agents; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor

2002